US Proposes Minimal Increase in Medicare Advantage Payments
The US government proposed a 0.09% increase in Medicare Advantage payments for 2026, leading to a sharp decline in health insurer stocks. This unexpected move impacts companies heavily reliant on these revenues.
Insights:
The US 
USgovernment has announced a proposed 0.09% increase in Medicare Advantage payments for 2026, a figure that falls significantly below market expectations. This unexpected proposal has led to a substantial decline in the stock prices of major health insurers, with shares falling between 5% and 13% in after-hours trading. The announcement is a critical development for companies heavily dependent on Medicare Advantage revenues.
USgovernment has announced a proposed 0.09% increase in Medicare Advantage payments for 2026, a figure that falls significantly below market expectations. This unexpected proposal has led to a substantial decline in the stock prices of major health insurers, with shares falling between 5% and 13% in after-hours trading. The announcement is a critical development for companies heavily dependent on Medicare Advantage revenues.The proposal, which reflects cost trends, quality ratings, and changes to the risk adjustment model, has caught the market by surprise. Health insurers had anticipated a payment increase closer to 4-5% due to rising costs and utilization. The stark deviation from expectations has raised concerns about the financial performance of major players in the sector, such as UnitedHealth Group Incorporated , CVS Health Corporation , and Humana Inc. .
